Get App Open
In App
Lending
Lending
Open App
you are here:

Torrent Pharmaceuticals Ltd.

BSE: 500420 | NSE: TORNTPHARM |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE685A01028 | SECTOR: Pharmaceuticals & Drugs

BSE Live

Oct 23, 16:01
3606.70 16.55 (0.46%)
Volume
AVERAGE VOLUME
5-Day
1,534
10-Day
1,918
30-Day
10,349
1,854
  • Prev. Close

    3590.15

  • Open Price

    3590.90

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Oct 23, 15:58
3614.10 23.20 (0.65%)
Volume
AVERAGE VOLUME
5-Day
160,441
10-Day
165,745
30-Day
252,501
240,712
  • Prev. Close

    3590.90

  • Open Price

    3572.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

Financials

Profit & Loss account of Torrent Pharmaceuticals (in Rs. Cr.) Mar 25 Mar 24 Mar 23 Mar 22 Mar 21  
  12 mths 12 mths 12 mths 12 mths 12 mths  
INCOME  
Revenue From Operations [Gross] 9,485.06 8,369.59 7,546.76 6,665.96 6,333.04  
Less: Excise/Sevice Tax/Other Levies 0.00 0.00 0.00 0.00 0.00  
Revenue From Operations [Net] 9,485.06 8,369.59 7,546.76 6,665.96 6,333.04  
Total Operating Revenues 9,682.44 8,532.90 7,695.20 6,742.32 6,450.57  
Other Income 31.50 91.36 81.88 204.17 118.34  
Total Revenue 9,713.94 8,624.26 7,777.08 6,946.49 6,568.91  
EXPENSES  
Cost Of Materials Consumed 1,517.51 1,651.91 1,477.42 1,528.60 1,420.82  
Purchase Of Stock-In Trade 732.33 548.48 533.56 397.24 398.99  
Operating And Direct Expenses 0.00 0.00 0.00 0.00 0.00  
Changes In Inventories Of FG,WIP And Stock-In Trade -9.04 -68.61 128.44 -18.34 -150.14  
Employee Benefit Expenses 1,636.45 1,450.67 1,251.22 1,097.93 1,097.12  
Finance Costs 213.40 303.04 297.68 236.29 334.12  
Depreciation And Amortisation Expenses 759.48 761.05 672.34 602.43 609.84  
Other Expenses 2,229.42 2,061.15 1,839.40 1,636.13 1,492.05  
Total Expenses 7,079.55 6,707.69 6,200.06 5,480.28 5,202.80  
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax 2,634.39 1,916.57 1,577.02 1,466.21 1,366.11  
Exceptional Items -24.21 0.00 0.00 0.00 0.00  
Profit/Loss Before Tax 2,610.18 1,916.57 1,577.02 1,466.21 1,366.11  
Tax Expenses-Continued Operations  
Current Tax 540.56 321.67 274.20 253.27 247.77  
Less: MAT Credit Entitlement 0.00 0.00 0.00 0.00 0.00  
Deferred Tax 181.56 237.82 251.43 221.49 -19.51  
Tax For Earlier Years 0.00 0.00 0.00 0.00 0.00  
Total Tax Expenses 722.12 559.49 525.63 474.76 228.26  
Profit/Loss After Tax And Before ExtraOrdinary Items 1,888.06 1,357.08 1,051.39 991.45 1,137.85  
Profit/Loss From Continuing Operations 1,888.06 1,357.08 1,051.39 991.45 1,137.85  
Profit/Loss For The Period 1,888.06 1,357.08 1,051.39 991.45 1,137.85  
OTHER ADDITIONAL INFORMATION  
EARNINGS PER SHARE  
Basic EPS (Rs.) 55.79 40.10 31.07 58.59 67.24  
Diluted EPS (Rs.) 55.79 40.10 31.07 58.59 67.24  
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS  
Imported Raw Materials 0.00 0.00 0.00 0.00 0.00  
Indigenous Raw Materials 0.00 0.00 0.00 0.00 0.00  
STORES, SPARES AND LOOSE TOOLS  
Imported Stores And Spares 0.00 0.00 0.00 0.00 0.00  
Indigenous Stores And Spares 0.00 0.00 0.00 0.00 0.00  
DIVIDEND AND DIVIDEND PERCENTAGE  
Equity Share Dividend 1,083.03 1,015.34 863.03 676.89 338.45  
Tax On Dividend 0.00 0.00 0.00 0.00 0.00  
Equity Dividend Rate (%) 640.00 560.00 440.00 960.00 700.00  
Source : Dion Global Solutions Limited

Results of Torrent Pharma